Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/22 20:49 | 8/8/22 | PSTX | Health | BioPrd | Biological Products, (No Diag | Malin Life Sciences Holdings Ltd | L2 | T | P | 7,525 | 3.50 | 0 | 2,150 | 22 | 11,836 | D | |||||||||||||||
8/10/22 18:13 | 8/8/22 | PSTX | Health | BioPrd | Biological Products, (No Diag | Ostertag Eric | CA | DOT | Exec CB | P | 500 | 3.50 | 0 | 143 | 2 | 9,399 | D | ||||||||||||||
3/18/22 20:01 | 3/16/22 | PSTX | Health | BioPrd | Biological Products, (No Diag | Ingalls Kerry D. | CA | O | COO | P | 12 | 3.98 | 0 | 3 | 6 | 55 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |